Tvardi Therapeutics (TVRD) Net Margin (2013 - 2025)
Tvardi Therapeutics (TVRD) recorded Net Margin of -372.87% in Q1 2025, down 176.05 percentage points from -196.81% a year earlier but up 500.46 percentage points from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Net Margin (2013 - 2025) Analysis & Trends
On a TTM basis, Tvardi Therapeutics' Net Margin came in at -459.31% as of Mar 31, 2025, up 107.76 percentage points year-over-year; for FY2024, it was -411.90%, up 153.31 percentage points from FY2023.
- Annual Net Margin has a five-year change of +123.02 percentage points (FY2019 to FY2024).
- Across earlier years, Net Margin came in at -565.21% in FY2023 (-361.05 pp), -204.16% in FY2022 (+179.90 pp), -384.06% in FY2021 (-390.28 pp) and 6.23% in FY2020 (+541.14 pp).
- Quarterly Net Margin has ranged from -4066.02% in Q4 2021 to 70.40% in Q4 2020 over the past five years.
- On a year-over-year basis, Net Margin rose in three of the last eight quarters, with an average year-over-year change of -71.27 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 3135.66 percentage points in Q4 2022, against a drop of 4136.42 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -873.33% (Q4 2024), -215.69% (Q3 2024) and -703.83% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Tvardi Therapeutics | 12.48 Mn | 12.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -372.87% |
| Dec 31, 2024 | -873.33% |
| Sep 30, 2024 | -215.69% |
| Jun 30, 2024 | -703.83% |
| Mar 31, 2024 | -196.81% |
| Dec 31, 2023 | -1,076.46% |
| Sep 30, 2023 | -576.08% |
| Jun 30, 2023 | -454.05% |
| Mar 31, 2023 | -432.52% |
| Dec 31, 2022 | -930.36% |
| Sep 30, 2022 | -214.37% |
| Jun 30, 2022 | -18.28% |
| Mar 31, 2022 | -579.31% |
| Dec 31, 2021 | -4,066.02% |
| Sep 30, 2021 | -5.00% |
| Mar 31, 2021 | -1,204.19% |
| Dec 31, 2020 | 70.40% |
| Sep 30, 2020 | -178.17% |
| Jun 30, 2020 | -444.94% |
| Mar 31, 2020 | -357.37% |
API Access
Tvardi Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();